Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07167537 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases

StatusRecruiting
PhasePhase 1
Started2025-10
View on ClinicalTrials.gov ↗
This study aims to characterize the safety, tolerability, pharmacokinetics, and preliminary efficacy of OL-CD19-GDT in relapsed/refractory autoimmune diseases.
Trial Details
NCT Number NCT07167537
Lead Sponsor Beijing GoBroad Hospital
Collaborators: Overland Therapeutics
Conditions Systemic Sclerosis (SSc), Primary Sjogren's Syndrome
Enrollment 44 participants
Start Date 2025-10
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-11